Explore recent issues of Contract Pharma covering key industry trends.
Read the full digital version of our magazine online.
Stay informed! Subscribe to Contract Pharma for industry news and analysis.
Get the latest updates and breaking news from the pharmaceutical and biopharmaceutical industry.
Discover the newest partnerships and collaborations within the pharma sector.
Keep track of key executive moves and promotions in the pharma and biopharma industry.
Updates on the latest clinical trials and regulatory filings.
Stay informed with the latest financial reports and updates in the pharma industry.
Expert Q&A sessions addressing crucial topics in the pharmaceutical and biopharmaceutical world.
In-depth articles and features covering critical industry developments.
Access exclusive industry insights, interviews, and in-depth analysis.
Insights and analysis from industry experts on current pharma issues.
A detailed look at the leading US players in the global pharmaceutical and BioPharmaceutical industry.
Browse companies involved in pharmaceutical manufacturing and services.
Comprehensive company profiles featuring overviews, key statistics, services, and contact details.
A comprehensive glossary of terms used in the pharmaceutical and biopharmaceutical industry.
Watch in-depth videos featuring industry insights and developments.
Listen to expert discussions and interviews in pharma and biopharma.
Download in-depth eBooks covering various aspects of the pharma industry.
Access detailed whitepapers offering analysis on industry topics.
View and download brochures from companies in the pharmaceutical sector.
Explore content sponsored by industry leaders, providing valuable insights.
Stay updated with the latest press releases from pharma and biopharma companies.
Explore top companies showcasing innovative pharma solutions.
Meet the leaders driving innovation and collaboration.
Engage with sessions and panels on pharma’s key trends.
Hear from experts shaping the pharmaceutical industry.
Join online webinars discussing critical industry topics and trends.
A comprehensive calendar of key industry events around the globe.
Live coverage and updates from major pharma and biopharma shows.
Find advertising opportunities to reach your target audience with Contract Pharma.
Review the editorial standards and guidelines for content published on our site.
Understand how Contract Pharma handles your personal data.
View the terms and conditions for using the Contract Pharma website.
What are you searching for?
An additional €60M financed by CDP will support investments in technology innovation, state-of-the-art machinery, and the modernization of a production plant.
March 8, 2023
By: Anthony Vecchione
Stevanato Group S.p.A., a global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries, announced two separate agreements with BNL BNP Paribas and Cassa Depositi e Prestiti Group (CDP) to obtain ESG-linked funds to support its ongoing global expansion. BNL BNP Paribas is participating in the financing with a contribution of €70 million, which is tied to two ESG-related objectives including increasing the company’s renewable-based energy and waste management improvements. An additional $60 million is being financed by CDP to be allocated to new investments in technological innovation, the purchase of state-of-the-art machinery, and the modernization of a production plant in Italy, which may generate employment opportunities, according to the company. In a statement, the company said that together, the financing agreements help solidify the company’s commitment to organic and sustainable growth. The company’s ongoing investments in the U.S., Italy and China will expand regional production and meet rising global demand for high-performance drug containment solutions. “In both the U.S. and Europe, we have been working alongside our customers to address their needs. With this added visibility, we see elevated demand in the coming years,” said Marco Dal Lago, chief financial officer of Stevanato Group. “The financing will help us expand much-needed capacity in the U.S., Italy, and China for our premium, high-value solutions to meet our customers’ needs, maximize organic growth, and build long-term shareholder value.” Mariaelena Gasparroni, BNL BNP Paribas Corporate Banking Director said: “In the spirit of partnership, thanks to sustainable finance instruments such as sustainability-linked loans, we continue to support Italian industries that are landmarks of the territories in which they operate and are recognized internationally as major players in their reference sectors.” Andrea Nuzzi, head of enterprise and financial institutions at CDP said, “We are proud to have concluded this agreement, which confirms CDP’s proximity to Italian entrepreneurship, rich in dynamic and cutting-edge companies that successfully project themselves towards pursuing ESG purposes. In this perspective, the ESG-linked financing in favor of Stevanato Group confirms CDP’s concrete commitment to promoting evolved sustainable finance instruments through initiatives characterized by high levels of additionality and innovativeness.”
Enter your account email.
A verification code was sent to your email, Enter the 6-digit code sent to your mail.
Didn't get the code? Check your spam folder or resend code
Set a new password for signing in and accessing your data.
Your Password has been Updated !